Episodes

  • Edge of escalation 🚀- Iran war escalates across the Middle East, AI gets blamed for more layoffs.

    Edge of escalation 🚀- Iran war escalates across the Middle East, AI gets blamed for more layoffs.
    Mar 2 2026
    In today's episode, we cover the escalating Iran conflict that's spreading across the Middle East and disrupting global oil markets, Block's massive AI-driven layoffs that cut nearly half its workforce, and the growing trend of "AI-washing" in corporate downsizing. Plus, we touch on the Pentagon's sudden switch from Anthropic to OpenAI, suspicious betting patterns on Polymarket around Iran strikes, and why your morning coffee might finally get cheaper thanks to Brazil's record harvest.
    Show More Show Less
    9 mins
  • Whopper wiretap 🍔- American nurses flock to B.C., Burger King tests Big Brother AI assistant.

    Whopper wiretap 🍔- American nurses flock to B.C., Burger King tests Big Brother AI assistant.
    Feb 27 2026
    In today's episode, we explore how American nurses are crossing the border to fill critical healthcare gaps in B.C., with over 1,000 U.S.-trained nurses joining the province since a streamlined licensing process was introduced. We also dive into Burger King's controversial new AI assistant "Patty," which will monitor employee interactions and friendliness at hundreds of locations. Plus, we cover Canada's new defence pact with South Korea, a major funding round for Montreal travel tech company Stay22, and why Nvidia's record profits still couldn't calm investor fears about AI valuations.
    Show More Show Less
    10 mins
  • Wake me up inside ⏰- Canada’s IPO market comes back to life, A Canadian billionaire’s grand folly.

    Wake me up inside ⏰- Canada’s IPO market comes back to life, A Canadian billionaire’s grand folly.
    Feb 26 2026
    In today's episode, we explore Canada's IPO market revival as Apotex plans a $1 billion public offering—the largest in five years. We also dive into Lawrence Stroll's troubled stewardship of Aston Martin Racing Team, as both the luxury automaker and F1 team face mounting challenges. Plus, Ottawa threatens to regulate OpenAI over safety concerns, Kalshi cracks down on insider trading, and Trump's trade representative confirms tariffs will remain part of any new deal with Canada.
    Show More Show Less
    10 mins
  • Bearish blogging 🐻- Viral Substack post is market mover, TikTok and the MLB join forces.

    Bearish blogging 🐻- Viral Substack post is market mover, TikTok and the MLB join forces.
    Feb 25 2026
    In today's episode, we explore how a viral Substack post about AI-driven economic disruption sparked a massive market selloff, wiping billions off tech stocks. We also cover the MLB's new partnership with TikTok to bring baseball highlights and creator content to younger audiences. Plus, US Treasury faces refund lawsuits after tariffs were struck down, new UK entry requirements for travelers, and Canadian airlines resuming flights to Mexico after violent unrest.
    Show More Show Less
    8 mins
  • Panic in Jalisco 🇲🇽 - Cartel violence hits Mexico after leader’s death, Aritzia revs up U.S. expansion.

    Panic in Jalisco 🇲🇽 - Cartel violence hits Mexico after leader’s death, Aritzia revs up U.S. expansion.
    Feb 24 2026
    In today's episode, we explore the aftermath of cartel leader El Mencho's death and the violent retaliation that erupted across Mexico, impacting travel safety for thousands of Canadians. We also dive into Aritzia's ambitious U.S. expansion as the Canadian retailer acquires iconic luxury brand Fred Segal and targets experiential retail on LA's Melrose Avenue. Plus, we cover OpenAI executives being summoned to Ottawa, Uber's robotaxi push, takeover interest in PayPal, and the latest on NEXUS suspensions affecting Canadian travelers.
    Show More Show Less
    10 mins
  • Hot water 🥵 - OpenAI is under fire for Tumbler Ridge shooting, Batteries become very cheap

    Hot water 🥵 - OpenAI is under fire for Tumbler Ridge shooting, Batteries become very cheap
    Feb 23 2026
    In today's episode, we cover OpenAI's controversial decision not to alert Canadian authorities about concerning ChatGPT conversations with the alleged Tumbler Ridge shooter, plus how plummeting battery costs are bringing us closer to a renewable energy future. We also discuss Trump's escalating global tariffs, the killing of a notorious Mexican cartel leader, and Netflix's Warner Bros. acquisition under DOJ scrutiny.
    Show More Show Less
    9 mins
  • Tamago sando 🥪 - 7-Eleven plans Canadian reinvention, AI might finally be impacting productivity.

    Tamago sando 🥪 - 7-Eleven plans Canadian reinvention, AI might finally be impacting productivity.
    Feb 20 2026
    In today's episode, we explore 7-Eleven Canada's ambitious expansion plans, including the arrival of the cult-favorite tamago sando from Japan as part of their shift toward becoming a quick-service restaurant. We also examine new evidence that AI may finally be impacting productivity levels across European firms and the U.S. job market. Plus, we cover OpenAI's massive $100 billion fundraising round, U.S. military buildup near Iran, the arrest of former Prince Andrew, and other headlines you gotta know.
    Show More Show Less
    9 mins
  • Criss-cross 🚷 - Another Conservative MP crosses the aisle, Hollywood bites back at ByteDance.

    Criss-cross 🚷 - Another Conservative MP crosses the aisle, Hollywood bites back at ByteDance.
    Feb 19 2026
    In today's episode, we explore the shifting political landscape as Conservative MP Matt Jeneroux becomes the third Tory to cross the floor and join the Liberal caucus, putting Prime Minister Carney on the verge of a majority government. We then dive into the entertainment industry's fight against ByteDance's revolutionary AI video generator Seedance 2.0, as Hollywood's biggest studios unite with cease-and-desist letters over copyright concerns. Plus, in our Big Picture segment, we examine the discovery of ancient antibiotic-resistant bacteria frozen in a Romanian ice cave and what it means for both public health and future medicine.
    Show More Show Less
    9 mins